27-hydroxycholesterol has been researched along with Local Neoplasm Recurrence in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Borgquist, S; Elebro, K; Inasu, M; Isaksson, K; Jernström, H; Jirström, K; Kimbung, S; Nodin, B; Stålhammar, T; Tryggvadottir, H; Ygland Rödström, M | 1 |
| Nelson, ER | 1 |
| Chang, CY; McDonnell, DP; Nelson, ER | 1 |
1 review(s) available for 27-hydroxycholesterol and Local Neoplasm Recurrence
| Article | Year |
|---|---|
The significance of cholesterol and its metabolite, 27-hydroxycholesterol in breast cancer.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cholesterol; Disease Models, Animal; Female; Humans; Hydroxycholesterols; Mice; Neoplasm Recurrence, Local; Prognosis; Receptors, Estrogen | 2018 |
2 other study(ies) available for 27-hydroxycholesterol and Local Neoplasm Recurrence
| Article | Year |
|---|---|
CYP27A1 expression is associated with risk of late lethal estrogen receptor-positive breast cancer in postmenopausal patients.
Topics: Aged; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Breast; Breast Neoplasms; Chemotherapy, Adjuvant; Cholestanetriol 26-Monooxygenase; Disease-Free Survival; Female; Follow-Up Studies; Humans; Hydroxycholesterols; Immunohistochemistry; Kaplan-Meier Estimate; Mastectomy; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Postmenopause; Prognosis; Receptors, Estrogen; Time Factors | 2020 |
The estrogen receptor as a mediator of the pathological actions of cholesterol in breast cancer.
Topics: Animals; Autocrine Communication; Breast Neoplasms; Cholesterol; Cholesterol, Dietary; Disease Models, Animal; Estrogen Receptor alpha; Female; Humans; Hydroxycholesterols; Hyperlipidemias; Incidence; Neoplasm Recurrence, Local; Obesity; Paracrine Communication; Receptors, Estrogen; Risk Factors; Selective Estrogen Receptor Modulators | 2014 |